Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).
Langdahl, Bente L
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). [electronic resource] - Calcified tissue international Dec 2009 - 484-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1432-0827
10.1007/s00223-009-9299-6 doi
Aged
Back Pain--epidemiology
Bone Density Conservation Agents--therapeutic use
Europe
Female
Fractures, Bone--epidemiology
Humans
Osteoporosis, Postmenopausal--complications
Pain Measurement
Quality of Life
Teriparatide--therapeutic use
Time Factors
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). [electronic resource] - Calcified tissue international Dec 2009 - 484-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1432-0827
10.1007/s00223-009-9299-6 doi
Aged
Back Pain--epidemiology
Bone Density Conservation Agents--therapeutic use
Europe
Female
Fractures, Bone--epidemiology
Humans
Osteoporosis, Postmenopausal--complications
Pain Measurement
Quality of Life
Teriparatide--therapeutic use
Time Factors